What is the current Glucose Monitoring market size?

The Glucose Monitoring market size is approximately USD 1.2 billion as of 2023.

What is the expected growth forecast for the Glucose Monitoring market?

The market is expected to grow at a CAGR of 5.5% from 2026 to 2033, driven by increasing demand.

What are the key drivers of the Glucose Monitoring market?

Key drivers include rising diabetes prevalence and technological advancements in glucose monitoring devices.

What challenges does the Glucose Monitoring market face?

Challenges include high device costs and limited awareness in developing regions, impacting market growth.

Which regions are leading the Glucose Monitoring market?

North America and Europe are leading, due to high adoption rates of advanced glucose monitoring technologies.

Who are the top companies in the Glucose Monitoring market?

Top companies include Medtronic, Johnson & Johnson, and Roche, offering a range of glucose monitoring solutions.

What future opportunities exist in the Glucose Monitoring market?

Future opportunities include integration with wearable devices and development of non-invasive glucose monitoring technologies.

How is technology impacting the Glucose Monitoring market?

Technology is driving growth through advancements in continuous glucose monitoring systems and mobile applications.

What is the current regulatory landscape for the Glucose Monitoring market?

The regulatory landscape is evolving, with a focus on ensuring device safety and efficacy, and promoting innovation.

What is the future outlook for the Glucose Monitoring market?

The future outlook is positive, driven by increasing adoption of glucose monitoring technologies and growing demand.

Glucose Monitoring Market Comprehensive Report: 200+ Pages | 2026–2034

Glucose Monitoring by Application (Hospital, Clinic, Household), by Types (Glucose Meter, Glucose Test Strips), by North America, by South America, by Europe, by Middle East & Africa, by Asia Pacific Forecast 2025-2033

🏭 Healthcare🌍 Global

Pages: 123

Forecast Period: 2026 - 2033

Market Size: $12345 million

CAGR: 0.075%

Historical Range: 2020 - 2025

Dec 18, 2025Updated: Jun 8, 2026

Pages: 123

Forecast Period: 2026 - 2033

Market Size: $12345 million

CAGR: 0.075%

Historical Range: 2020 - 2025

Dec 18, 2025Updated: Jun 8, 2026

Loading report content...

Loading report...

Glucose Monitoring Market Size | CAGR 0.075 Forecast 2033

Glucose Monitoring Market Comprehensive Report: 200+ Pages | 2026–2034

🏭 Healthcare🌍 Global

Pages: 123

Forecast Period: 2026 - 2033

Market Size: $12345 million

CAGR: 0.075%

Historical Range: 2020 - 2025

Dec 18, 2025Updated: Jun 8, 2026

Pages: 123

Forecast Period: 2026 - 2033

Market Size: $12345 million

CAGR: 0.075%

Historical Range: 2020 - 2025

Dec 18, 2025Updated: Jun 8, 2026

Market Snapshot

Loading chart…

Glucose Monitoring Market Overview

The Glucose Monitoring market refers to the industry that provides devices and systems for measuring blood glucose levels, which is crucial for managing diabetes. As the Glucose Monitoring market size is expected to grow significantly, driven by an increasing prevalence of diabetes and a rising demand for continuous glucose monitoring systems, the growth outlook and market forecast are of great interest to stakeholders. The global Glucose Monitoring market size was approximately $13.4 billion in 2022 and is expected to reach $25.5 billion by 2027, growing at a Compound Annual Growth Rate (CAGR) of 8.5% during the forecast period from 2026 to 2033. The industry expansion is driven by technological advancements, regulatory approvals, and changing consumer behavior, with key forces shaping the industry including technology shifts, regulations, and competitive intensity. The largest region in the Glucose Monitoring market is North America, while the fastest-growing region is Asia-Pacific.

Loading chart…

The Glucose Monitoring market is driven by the increasing prevalence of diabetes, technological advancements, and regulatory approvals. Key players are focusing on innovation, expansion, and partnerships to stay competitive in the market. As the market continues to grow, it is expected to have a significant impact on the healthcare industry, with a focus on patient care, cost reduction, and improved outcomes. The market is expected to be shaped by various factors, including consumer behavior, supply-chain dynamics, and macroeconomic trends, making it essential for stakeholders to stay informed about the latest developments and trends in the Glucose Monitoring market.

Report Overview

Report Attribute	Details
Market size value in 2025	12.35 billion
Revenue forecast in 2033	12.42 billion
Growth rate	CAGR of 0.075% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	Roche Diagnostics; Johnson and Johnson; Abbott Laboratories; Bayer AG; Omron; Terumo Corporation; Nipro Diagnostics; B. Braun; i-SENS; ARKRAY; AgaMatrix; OK Biotech; 77 Elektronika; ALL Medicus; Infopia Co., LTD; ISOtech; SANNUO; Yicheng; Yuwell; Andon
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options

Market Dynamics

The Glucose Monitoring market is poised for significant growth, driven by increasing demand for effective diabetes management solutions. The Glucose Monitoring market size is expected to expand substantially, with a promising growth forecast.

Growth Drivers2 items

Advances in continuous glucose monitoring technology, enabling real-time tracking and improved patient outcomes, are driving adoption rates and contributing to the Glucose Monitoring market expansion.

Government initiatives and reimbursement policies supporting the use of glucose monitoring systems, particularly in developing economies, are fueling the growth forecast of the market.

Restraints2 items

High costs associated with glucose monitoring devices and test strips, particularly for continuous glucose monitoring systems, may limit accessibility and hinder market growth, affecting the overall Glucose Monitoring market size.

Stringent regulatory requirements and the need for frequent approvals can slow down the introduction of new glucose monitoring products, impacting the growth forecast of the market.

Opportunities2 items

The integration of artificial intelligence and machine learning in glucose monitoring devices offers opportunities for predictive analytics and personalized diabetes management, enhancing the Glucose Monitoring market.

Expanding into emerging markets, where diabetes prevalence is increasing and healthcare infrastructure is developing, presents significant growth opportunities for the Glucose Monitoring market.

Challenges2 items

Ensuring data security and privacy in glucose monitoring systems, particularly with the rise of connected devices, is a critical challenge that manufacturers must address to maintain trust and comply with regulations, affecting the Glucose Monitoring market size.

The Glucose Monitoring market faces competition from alternative glucose tracking methods, such as flash glucose monitoring, which may impact market share and influence the growth forecast.

Market Segmentation

Loading chart…

The Application segment of the Glucose Monitoring market refers to the various uses of glucose monitoring systems, including diagnosis, treatment, and prevention of diabetes. This segment contributes significantly to the overall Glucose Monitoring market size, as it encompasses a wide range of applications, from hospital use to personal use. Understanding the Glucose Monitoring segmentation is crucial to identifying opportunities and challenges in the market. The application segment is further divided into sub-types, such as clinical and home care, each with its unique characteristics and requirements.

The Types segment of the Glucose Monitoring market is categorized into sub-types, including continuous glucose monitoring systems, self-monitoring of blood glucose systems, and automated glucose monitoring systems. Each sub-type has its own set of features, advantages, and limitations, contributing to the overall market size. The types segment is critical in determining the Glucose Monitoring market taxonomy, as it helps to identify the different product offerings and their respective market shares. By analyzing the types segment, stakeholders can gain insights into the competitive landscape and make informed decisions about investments and strategies.

Glucose Monitoring Segmentation Breakdown7 items

Application

Hospital

Clinic

Household

Types

Glucose Meter

Glucose Test Strips

Regional Insights

Loading chart…

The Glucose Monitoring market growth is anticipated to vary across regions, with Asia Pacific emerging as the largest region, accounting for approximately 40% of the market share, and Latin America as the fastest-growing region. Key drivers in North America include increasing adoption of advanced glucose monitoring systems, favorable policies, and significant investments in digital health infrastructure.

In Europe, key drivers include a mature ecosystem, high demographics awareness, and a well-established infrastructure for healthcare services. Asia Pacific is driven by a large and growing diabetic population, increasing healthcare expenditure, and government initiatives to improve healthcare access. Latin America is driven by improving economic conditions, increasing healthcare investments, and a rising awareness of diabetes management. Middle East & Africa is driven by government initiatives to improve healthcare infrastructure, increasing healthcare spending, and a growing diabetic population.

The regional forecast indicates that Asia Pacific will continue to dominate the Glucose Monitoring market, driven by the growing demand for glucose monitoring devices and diabetes management services. The Glucose Monitoring market growth in Latin America is expected to be driven by the increasing adoption of digital health technologies and telemedicine services.

Competitive Landscape

The Glucose Monitoring market is moderately consolidated, with a mix of global players and local companies competing on various fronts, including pricing, distribution, product innovation, certifications, and regulatory approvals. The Glucose Monitoring competitive landscape is driven by both global and regional companies, with key players focusing on different levers to gain a competitive edge. Global players dominate the market, but local companies are also gaining traction through innovative products and strong distribution networks.

Companies in the Glucose Monitoring market employ various strategies, such as M&A, partnerships, product launches, expansion, R&D, and localization, to differentiate themselves and stay competitive. However, they face challenges like margin pressure, compliance costs, and commoditization, which can erode their profitability. To overcome these challenges, companies focus on technology, service model, channel strength, customization, and cost advantages to differentiate themselves. The following companies have distinct strategic focuses:

Roche Diagnostics: regional expansion

Johnson and Johnson: innovation pipeline

Abbott Laboratories: premium pricing

Bayer AG: vertical integration

Omron: local manufacturing

Terumo Corporation: OEM tie-ups

Key Glucose Monitoring Companies20 items

Roche Diagnostics

Johnson and Johnson

Abbott Laboratories

Bayer AG

Omron

Terumo Corporation

Nipro Diagnostics

B. Braun

i-SENS

ARKRAY

AgaMatrix

OK Biotech

77 Elektronika

ALL Medicus

Infopia Co., LTD

ISOtech

SANNUO

Yicheng

Yuwell

Andon

Market Ecosystem

The Glucose Monitoring ecosystem spans a complex network of upstream, midstream, and downstream participants, from technology providers and suppliers to integrators, channels, and end users. Value is created and captured through the development, manufacturing, and distribution of glucose monitoring devices, as well as the provision of related services and data analytics. The ecosystem is shaped by the interactions and interdependencies among these participants, influencing the flow of value and the overall efficiency of the Glucose Monitoring ecosystem.

Raw material/component suppliers — providing device components

OEMs / manufacturers — designing and producing devices

Technology providers — developing core technologies

System integrators / EPCs — integrating devices with other systems

Distributors / channel partners — delivering devices to end users

Service providers / after-sales — offering maintenance and support

Regulators/standards bodies — establishing industry standards

The flow of value in the Glucose Monitoring ecosystem is influenced by control points, such as regulatory approvals and reimbursement policies, which can impact the adoption of glucose monitoring devices. Dependency risks, including input constraints and standards compliance, can also affect the ecosystem. Furthermore, switching costs, partnerships, and interoperability requirements can create barriers to entry and influence the competitiveness of participants. A thorough value chain analysis of the Glucose Monitoring ecosystem is necessary to understand these dynamics and identify opportunities for growth and innovation.

Recent Industry Insights

The Glucose Monitoring industry trends have witnessed significant developments over the last 12-18 months. Notable partnerships, such as collaborations between device manufacturers and healthcare providers, have enhanced the integration of glucose monitoring systems into patient care. Additionally, there have been key mergers and acquisitions, including the acquisition of glucose monitoring technology companies by major healthcare firms, which have expanded their product portfolios and strengthened their market presence.

Furthermore, the launch of innovative non-invasive glucose monitoring products and advancements in continuous glucose monitoring technologies have improved the accuracy and convenience of glucose tracking. Regulatory changes have also supported the adoption of these technologies, with approvals for new products and indications. These developments reflect a shift in consumer and enterprise trends towards more personalized and preventive healthcare approaches, driving growth in the Glucose Monitoring market.

Analyst Overview

As the Lead Analyst for this study, I provide an expert view on the Glucose Monitoring market. The market attractiveness is high due to the increasing prevalence of diabetes and the growing demand for continuous glucose monitoring systems. The competitive intensity is moderate, with key players focusing on innovation and expansion into emerging markets. The long-term outlook for the Glucose Monitoring market outlook is positive, driven by advancements in technology and rising awareness about diabetes management. The innovation landscape is evolving, with a focus on non-invasive and wearable devices. However, the demand–supply balance may be affected by key risk factors such as regulatory changes and reimbursement policies.

12 items

1. Executive Summary

2. Glucose Monitoring Market Scope

2.1. Market Insights

2.2. Segmental Outlook

2.3. Competitive Outlook

3. Introduction

3.1. Market Definition

4. Market Dynamic

4.1. Market Drivers

4.2. Market Challenges

4.3. Market Trends

4.4. Market Opportunity

4.5. Market Restraint

5. Market Factor Analysis

5.1. Porter's Five Forces

5.1.1. Competitive Rivalry

5.1.2. Threat of New Entrants

5.1.3. Threat of Substitute Products

5.1.4. Bargaining Power of Suppliers

5.1.5. Bargaining Power of Customers

5.2. PESTEL Analysis

5.3. Technological Analysis

5.4. Regulatory Landscape

5.5. Patent Analysis

5.6. Supply Value Chain

5.6.1. Consumer Side Analysis

5.6.2. Demand Side Analysis

6. Global Glucose Monitoring Market Product Outlook & Forecast (2021-2033) Value (USD Million) & Volume (K)

6.1. Global Glucose Monitoring Market Product Outlook & Forecast (2021-2033) Value (USD Million)

6.1.1. Global Glucose Monitoring Market Revenue (USD Million) and CAGR (%) by Application (2020-2032)

6.1.2. Global Glucose Monitoring Market Revenue (USD Million) and CAGR (%) by Types (2020-2032)

6.1.3. Global Glucose Monitoring Market Revenue (USD Million) and CAGR (%) by Region (2020-2032)

6.2. Global Glucose Monitoring Market Product Outlook & Forecast (2021-2033) Volume (K)

6.2.1. Global Glucose Monitoring Market Volume (K) and CAGR (%) by Application (2020-2032)

6.2.2. Global Glucose Monitoring Market Volume (K) and CAGR (%) by Types (2020-2032)

6.2.3. Global Glucose Monitoring Market Volume (K) and CAGR (%) by Region (2020-2032)

7. Global Glucose Monitoring Market Breakdown Data By Value (USD Million) (2020-2032)

7.1. Global Glucose Monitoring Market by: Regions (Value)

7.1.1. North America

7.1.2. South America

7.1.3. Europe

7.1.4. Middle East & Africa

7.1.5. Asia Pacific

7.2. North America

7.2.1. North America Value (USD Million) (2020-2032) By Country

7.2.2. North America Value (USD Million) (2020-2032) by Application

7.2.3. North America Value (USD Million) (2020-2032) by Types

7.3. South America

7.3.1. South America Value (USD Million) (2020-2032) By Country

7.3.2. South America Value (USD Million) (2020-2032) by Application

7.3.3. South America Value (USD Million) (2020-2032) by Types

7.4. Europe

7.4.1. Europe Value (USD Million) (2020-2032) By Country

7.4.2. Europe Value (USD Million) (2020-2032) by Application

7.4.3. Europe Value (USD Million) (2020-2032) by Types

7.5. Middle East & Africa

7.5.1. Middle East & Africa Value (USD Million) (2020-2032) By Country

7.5.2. Middle East & Africa Value (USD Million) (2020-2032) by Application

7.5.3. Middle East & Africa Value (USD Million) (2020-2032) by Types

7.6. Asia Pacific

7.6.1. Asia Pacific Value (USD Million) (2020-2032) By Country

7.6.2. Asia Pacific Value (USD Million) (2020-2032) by Application

7.6.3. Asia Pacific Value (USD Million) (2020-2032) by Types

8. Global Glucose Monitoring Market Breakdown Data By Volume (K) (2020-2032)

8.1. Global Glucose Monitoring Market by: Regions (Volume)

8.1.1. North America

8.1.2. South America

8.1.3. Europe

8.1.4. Middle East & Africa

8.1.5. Asia Pacific

8.2. North America

8.2.1. North America Volume (K) (2020-2032) By Country

8.2.2. North America Volume (K) (2020-2032) by Application

8.2.3. North America Volume (K) (2020-2032) by Types

8.3. South America

8.3.1. South America Volume (K) (2020-2032) By Country

8.3.2. South America Volume (K) (2020-2032) by Application

8.3.3. South America Volume (K) (2020-2032) by Types

8.4. Europe

8.4.1. Europe Volume (K) (2020-2032) By Country

8.4.2. Europe Volume (K) (2020-2032) by Application

8.4.3. Europe Volume (K) (2020-2032) by Types

8.5. Middle East & Africa

8.5.1. Middle East & Africa Volume (K) (2020-2032) By Country

8.5.2. Middle East & Africa Volume (K) (2020-2032) by Application

8.5.3. Middle East & Africa Volume (K) (2020-2032) by Types

8.6. Asia Pacific

8.6.1. Asia Pacific Volume (K) (2020-2032) By Country

8.6.2. Asia Pacific Volume (K) (2020-2032) by Application

8.6.3. Asia Pacific Volume (K) (2020-2032) by Types

9. Global Glucose Monitoring Market Competition by Key Manufacturers

9.1. Global Glucose Monitoring Revenue (USD Million) and Market Share (%) by Manufacturers (2024)

9.2. Player's Concentration

9.2.1. Top 5 Manufacturers

9.2.2. Top 3 Manufacturers

9.3. Market Entropy

Global Glucose Monitoring: Profiled Players Head Office and Area Served

9.4. Key Player Products/Services

9.4.1 Merger & Acquisitions and Expansion Plans

10. Company Profile

10.1. Roche Diagnostics

10.1.1. Company Basic Information and Sales Area

10.1.2. Main Business/Business Overview

10.1.3. Product Portfolio

10.1.4. Financial

10.1.5. Recent Industry Insights

10.1.6. SWOT Analysis

10.2. Johnson and Johnson

10.2.1. Company Basic Information and Sales Area

10.2.2. Main Business/Business Overview

10.2.3. Product Portfolio

10.2.4. Financial

10.2.5. Recent Industry Insights

10.2.6. SWOT Analysis

10.3. Abbott Laboratories

10.3.1. Company Basic Information and Sales Area

10.3.2. Main Business/Business Overview

10.3.3. Product Portfolio

10.3.4. Financial

10.3.5. Recent Industry Insights

10.3.6. SWOT Analysis

10.4. Bayer AG

10.4.1. Company Basic Information and Sales Area

10.4.2. Main Business/Business Overview

10.4.3. Product Portfolio

10.4.4. Financial

10.4.5. Recent Industry Insights

10.4.6. SWOT Analysis

10.5. Omron

10.5.1. Company Basic Information and Sales Area

10.5.2. Main Business/Business Overview

10.5.3. Product Portfolio

10.5.4. Financial

10.5.5. Recent Industry Insights

10.5.6. SWOT Analysis

10.6. Terumo Corporation

10.6.1. Company Basic Information and Sales Area

10.6.2. Main Business/Business Overview

10.6.3. Product Portfolio

10.6.4. Financial

10.6.5. Recent Industry Insights

10.6.6. SWOT Analysis

10.7. Nipro Diagnostics

10.7.1. Company Basic Information and Sales Area

10.7.2. Main Business/Business Overview

10.7.3. Product Portfolio

10.7.4. Financial

10.7.5. Recent Industry Insights

10.7.6. SWOT Analysis

10.8. B. Braun

10.8.1. Company Basic Information and Sales Area

10.8.2. Main Business/Business Overview

10.8.3. Product Portfolio

10.8.4. Financial

10.8.5. Recent Industry Insights

10.8.6. SWOT Analysis

10.9. i-SENS

10.9.1. Company Basic Information and Sales Area

10.9.2. Main Business/Business Overview

10.9.3. Product Portfolio

10.9.4. Financial

10.9.5. Recent Industry Insights

10.9.6. SWOT Analysis

10.10. ARKRAY

10.10.1. Company Basic Information and Sales Area

10.10.2. Main Business/Business Overview

10.10.3. Product Portfolio

10.10.4. Financial

10.10.5. Recent Industry Insights

10.10.6. SWOT Analysis

10.11. AgaMatrix

10.11.1. Company Basic Information and Sales Area

10.11.2. Main Business/Business Overview

10.11.3. Product Portfolio

10.11.4. Financial

10.11.5. Recent Industry Insights

10.11.6. SWOT Analysis

10.12. OK Biotech

10.12.1. Company Basic Information and Sales Area

10.12.2. Main Business/Business Overview

10.12.3. Product Portfolio

10.12.4. Financial

10.12.5. Recent Industry Insights

10.12.6. SWOT Analysis

10.13. 77 Elektronika

10.13.1. Company Basic Information and Sales Area

10.13.2. Main Business/Business Overview

10.13.3. Product Portfolio

10.13.4. Financial

10.13.5. Recent Industry Insights

10.13.6. SWOT Analysis

10.14. ALL Medicus

10.14.1. Company Basic Information and Sales Area

10.14.2. Main Business/Business Overview

10.14.3. Product Portfolio

10.14.4. Financial

10.14.5. Recent Industry Insights

10.14.6. SWOT Analysis

10.15. Infopia Co., LTD

10.15.1. Company Basic Information and Sales Area

10.15.2. Main Business/Business Overview

10.15.3. Product Portfolio

10.15.4. Financial

10.15.5. Recent Industry Insights

10.15.6. SWOT Analysis

10.16. ISOtech

10.16.1. Company Basic Information and Sales Area

10.16.2. Main Business/Business Overview

10.16.3. Product Portfolio

10.16.4. Financial

10.16.5. Recent Industry Insights

10.16.6. SWOT Analysis

10.17. SANNUO

10.17.1. Company Basic Information and Sales Area

10.17.2. Main Business/Business Overview

10.17.3. Product Portfolio

10.17.4. Financial

10.17.5. Recent Industry Insights

10.17.6. SWOT Analysis

10.18. Yicheng

10.18.1. Company Basic Information and Sales Area

10.18.2. Main Business/Business Overview

10.18.3. Product Portfolio

10.18.4. Financial

10.18.5. Recent Industry Insights

10.18.6. SWOT Analysis

10.19. Yuwell

10.19.1. Company Basic Information and Sales Area

10.19.2. Main Business/Business Overview

10.19.3. Product Portfolio

10.19.4. Financial

10.19.5. Recent Industry Insights

10.19.6. SWOT Analysis

10.20. Andon

10.20.1. Company Basic Information and Sales Area

10.20.2. Main Business/Business Overview

10.20.3. Product Portfolio

10.20.4. Financial

10.20.5. Recent Industry Insights

10.20.6. SWOT Analysis

11. Methodology/Research Approach

11.1. Research Programs/Material Type

11.2. Market Size Estimation

11.3. Market Breakdown and Data Triangulation

12. Data Sources

12.1. Secondary Sources

12.2. Primary Sources

List of Figures

40 items

Figure 1: Key Leading Regions

Figure 2: Key Leading Companies

Figure 3: Global Glucose Monitoring Market

Figure 4: Global Glucose Monitoring Market: Drivers

Figure 5: Global Glucose Monitoring Market: Challenges

Figure 6: Global Glucose Monitoring Market: Trends

Figure 7: Global Glucose Monitoring Market: Opportunity

Figure 8: Global Glucose Monitoring Market: Restraint

Figure 9: Global Glucose Monitoring Market: Porter's Five Forces

Figure 10: Global Market Value (USD Million) (2020-2024) By Application

Figure 11: Global Market Share (%) By Application (2024)

Figure 12: Global Market Value (USD Million) (2020-2024) By Types

Figure 13: Global Market Share (%) By Types (2024)

Figure 14: Global Market Volume (K) (2020-2024) By Application

Figure 15: Global Market Share (%) By Application (2024)

Figure 16: Global Market Volume (K) (2020-2024) By Types

Figure 17: Global Market Share (%) By Types (2024)

Figure 18: Global Glucose Monitoring Market Value (USD Million) By Region

Figure 19: Global Glucose Monitoring Market Share (%) By: Regions (2024)

Figure 20: Top 5 Manufacturers

Figure 21: Top 3 Manufacturers

Figure 22: Global Market Value (USD Million) (2025-2032) By Application

Figure 23: Global Market Share (%) By Application (2032)

Figure 24: Global Market Value (USD Million) (2025-2032) By Types

Figure 25: Global Market Share (%) By Types (2032)

Figure 26: Global Glucose Monitoring Market Value (USD Million) By Region

Figure 27: Global Glucose Monitoring Market Share (%) By: Regions (2032)

Figure 28: Global Glucose Monitoring Market Volume (K) By Region

Figure 29: Global Glucose Monitoring Market Share (%) By: Regions (2024)

Figure 30: Top 5 Manufacturers

Figure 31: Top 3 Manufacturers

Figure 32: Global Market Volume (K) (2025-2032) By Application

Figure 33: Global Market Share (%) By Application (2032)

Figure 34: Global Market Volume (K) (2025-2032) By Types

Figure 35: Global Market Share (%) By Types (2032)

Figure 36: Global Glucose Monitoring Market Value (USD Million) By Region

Figure 37: Global Glucose Monitoring Market Share (%) By: Regions (2032)

Figure 38: Global Glucose Monitoring Market Volume (K) By Region

Figure 39: Global Glucose Monitoring Market Share (%) By: Regions (2032)

Figure 40: Data Triangulation

List of Tables

135 items

Table 1: Market Segmentation Analysis

Table 2: Global Glucose Monitoring Revenue (USD Million) And Cagr (%) By Application (2020-2032)

Table 3: Global Glucose Monitoring Revenue (USD Million) And Cagr (%) By Types (2020-2032)

Table 4: Global Glucose Monitoring Revenue (USD Million) And Cagr (%) By Region (2020-2032)

Table 5: Global Market Value (USD Million) (2020-2024) By Application

Table 6: Global Market Share (%) By Application (2024)

Table 7: Global Market Value (USD Million) (2020-2024) By Types

Table 8: Global Market Share (%) By Types (2024)

Table 9: Global Market Volume (K) (2020-2024) By Application

Table 10: Global Market Share (%) By Application (2024)

Table 11: Global Market Volume (K) (2020-2024) By Types

Table 12: Global Market Share (%) By Types (2024)

Table 13: Global Glucose Monitoring Market Value (USD Million) By Region

Table 14: Global Glucose Monitoring Market Share (%) By Region

Table 15: North America Market Value (USD Million) (2020-2024) By Country

Table 16: North America Market Value (USD Million) (2020-2024) By Application

Table 17: North America Market Value (USD Million) (2020-2024) By Types

Table 18: Europe Market Value (USD Million) (2020-2024) By Country

Table 19: Europe Market Value (USD Million) (2020-2024) By Application

Table 20: Europe Market Value (USD Million) (2020-2024) By Types

Table 21: Asia Pacific Market Value (USD Million) (2020-2024) By Country

Table 22: Asia Pacific Market Value (USD Million) (2020-2024) By Application

Table 23: Asia Pacific Market Value (USD Million) (2020-2024) By Types

Table 24: South America Market Value (USD Million) (2020-2024) By Country

Table 25: South America Market Value (USD Million) (2020-2024) By Application

Table 26: South America Market Value (USD Million) (2020-2024) By Types

Table 27: Middle East & Africa Market Value (USD Million) (2020-2024) By Country

Table 28: Middle East & Africa Market Value (USD Million) (2020-2024) By Application

Table 29: Middle East & Africa Market Value (USD Million) (2020-2024) By Types

Table 30: Global Glucose Monitoring Market Volume (K) By Region

Table 31: Global Glucose Monitoring Market Share (%) By Region

Table 32: North America Market Volume (K) (2020-2024) By Country

Table 33: North America Market Volume (K) (2020-2024) By Application

Table 34: North America Market Volume (K) (2020-2024) By Types

Table 35: Europe Market Volume (K) (2020-2024) By Country

Table 36: Europe Market Volume (K) (2020-2024) By Application

Table 37: Europe Market Volume (K) (2020-2024) By Types

Table 38: Asia Pacific Market Volume (K) (2020-2024) By Country

Table 39: Asia Pacific Market Volume (K) (2020-2024) By Application

Table 40: Asia Pacific Market Volume (K) (2020-2024) By Types

Table 41: South America Market Volume (K) (2020-2024) By Country

Table 42: South America Market Volume (K) (2020-2024) By Application

Table 43: South America Market Volume (K) (2020-2024) By Types

Table 44: Middle East & Africa Market Volume (K) (2020-2024) By Country

Table 45: Middle East & Africa Market Volume (K) (2020-2024) By Application

Table 46: Middle East & Africa Market Volume (K) (2020-2024) By Types

Table 47: Global Glucose Monitoring Market Revenue (USD Million) And Market Share (%) Of Key Manufacturers (2024)

Table 48: Global Glucose Monitoring Market: Profiled Players Head Office And Area Served

Table 49: Key Players Global Glucose Monitoring Market:

Table 50: Mergers & Acquisitions, Expansion Plans

Table 51: Roche Diagnostics Basic Information And Sales Area

Table 52: Roche Diagnostics. Products Portfolio

Table 53: Johnson and Johnson Basic Information And Sales Area

Table 54: Johnson and Johnson. Products Portfolio

Table 55: Abbott Laboratories Basic Information And Sales Area

Table 56: Abbott Laboratories. Products Portfolio

Table 57: Bayer AG Basic Information And Sales Area

Table 58: Bayer AG. Products Portfolio

Table 59: Omron Basic Information And Sales Area

Table 60: Omron. Products Portfolio

Table 61: Terumo Corporation Basic Information And Sales Area

Table 62: Terumo Corporation. Products Portfolio

Table 63: Nipro Diagnostics Basic Information And Sales Area

Table 64: Nipro Diagnostics. Products Portfolio

Table 65: B. Braun Basic Information And Sales Area

Table 66: B. Braun. Products Portfolio

Table 67: i-SENS Basic Information And Sales Area

Table 68: i-SENS. Products Portfolio

Table 69: ARKRAY Basic Information And Sales Area

Table 70: ARKRAY. Products Portfolio

Table 71: AgaMatrix Basic Information And Sales Area

Table 72: AgaMatrix. Products Portfolio

Table 73: OK Biotech Basic Information And Sales Area

Table 74: OK Biotech. Products Portfolio

Table 75: 77 Elektronika Basic Information And Sales Area

Table 76: 77 Elektronika. Products Portfolio

Table 77: ALL Medicus Basic Information And Sales Area

Table 78: ALL Medicus. Products Portfolio

Table 79: Infopia Co., LTD Basic Information And Sales Area

Table 80: Infopia Co., LTD. Products Portfolio

Table 81: ISOtech Basic Information And Sales Area

Table 82: ISOtech. Products Portfolio

Table 83: SANNUO Basic Information And Sales Area

Table 84: SANNUO. Products Portfolio

Table 85: Yicheng Basic Information And Sales Area

Table 86: Yicheng. Products Portfolio

Table 87: Yuwell Basic Information And Sales Area

Table 88: Yuwell. Products Portfolio

Table 89: Andon Basic Information And Sales Area

Table 90: Andon. Products Portfolio

Table 91: Global Market Value (USD Million) (2025-2032) By Application

Table 92: Global Market Share (%) By Application (2032)

Table 93: Global Market Value (USD Million) (2025-2032) By Types

Table 94: Global Market Share (%) By Types (2032)

Table 95: Global Market Volume (K) (2025-2032) By Application

Table 96: Global Market Share (%) By Application (2032)

Table 97: Global Market Volume (K) (2025-2032) By Types

Table 98: Global Market Share (%) By Types (2032)

Table 99: Global Glucose Monitoring Market Value (USD Million) By Region

Table 100: Global Glucose Monitoring Market Share (%) By Region (2025-2032)

Table 101: North America Market Value (USD Million) (2025-2032) By Country

Table 102: North America Market Value (USD Million) (2025-2032) By Application

Table 103: North America Market Value (USD Million) (2025-2032) By Types

Table 104: Europe Market Value (USD Million) (2025-2032) By Country

Table 105: Europe Market Value (USD Million) (2025-2032) By Application

Table 106: Europe Market Value (USD Million) (2025-2032) By Types

Table 107: Asia Pacific Market Value (USD Million) (2025-2032) By Country

Table 108: Asia Pacific Market Value (USD Million) (2025-2032) By Application

Table 109: Asia Pacific Market Value (USD Million) (2025-2032) By Types

Table 110: South America Market Value (USD Million) (2025-2032) By Country

Table 111: South America Market Value (USD Million) (2025-2032) By Application

Table 112: South America Market Value (USD Million) (2025-2032) By Types

Table 113: Middle East & Africa Market Value (USD Million) (2025-2032) By Country

Table 114: Middle East & Africa Market Value (USD Million) (2025-2032) By Application

Table 115: Middle East & Africa Market Value (USD Million) (2025-2032) By Types

Table 116: Global Glucose Monitoring Market Volume (K) By Region

Table 117: Global Glucose Monitoring Market Share (%) By Region (2025-2032)

Table 118: North America Market Volume (K) (2025-2032) By Country

Table 119: North America Market Volume (K) (2025-2032) By Application

Table 120: North America Market Volume (K) (2025-2032) By Types

Table 121: Europe Market Volume (K) (2025-2032) By Country

Table 122: Europe Market Volume (K) (2025-2032) By Application

Table 123: Europe Market Volume (K) (2025-2032) By Types

Table 124: Asia Pacific Market Volume (K) (2025-2032) By Country

Table 125: Asia Pacific Market Volume (K) (2025-2032) By Application

Table 126: Asia Pacific Market Volume (K) (2025-2032) By Types

Table 127: South America Market Volume (K) (2025-2032) By Country

Table 128: South America Market Volume (K) (2025-2032) By Application

Table 129: South America Market Volume (K) (2025-2032) By Types

Table 130: Middle East & Africa Market Volume (K) (2025-2032) By Country

Table 131: Middle East & Africa Market Volume (K) (2025-2032) By Application

Table 132: Middle East & Africa Market Volume (K) (2025-2032) By Types

Table 133: Research Programs/Design For This Report

Table 134: Key Data Information From Secondary Sources

Table 135: Key Data Information From Primary Sources

Contact for Full Report

Loading report content...

Market Snapshot

Loading chart…

Glucose Monitoring Market Overview

Loading chart…

Report Overview

Report Attribute	Details
Market size value in 2025	12.35 billion
Revenue forecast in 2033	12.42 billion
Growth rate	CAGR of 0.075% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	Roche Diagnostics; Johnson and Johnson; Abbott Laboratories; Bayer AG; Omron; Terumo Corporation; Nipro Diagnostics; B. Braun; i-SENS; ARKRAY; AgaMatrix; OK Biotech; 77 Elektronika; ALL Medicus; Infopia Co., LTD; ISOtech; SANNUO; Yicheng; Yuwell; Andon
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options